GST Council approves rate reduction for Remdesivir from 12% to 5%; nil tax on Tocilizumab, Amphotericin: FM.

GST Council approves rate reduction for Remdesivir from 12% to 5%; nil tax on Tocilizumab, Amphotericin: FM.